1. OC-0263 Altered activation of the immune response causes radioresistance in HR-impaired breast cancer cells. (May 2022) Authors: Classen, S.; Rahlf, E.; Jungwirth, J.; Poole, L.; Gehre, S.; Rückert, M.; Petersen, C.; Rothkamm, K.; Gaipl, U.; Pospiech, H.; Borgmann, K. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PH-0234: The Adaptive Resistome in TNBC: Functional Targeting in Patient-derived Organoids and Cell Lines. (November 2020) Authors: Classen, S.; Rahlf, E.; Görte, J.; Parplys, A.C.; Schumacher, U.; Petersen, C.; Rothkamm, K.; Toulany, M.; Cordes, N.; Borgmann, K. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PH-0234: The Adaptive Resistome in TNBC: Functional Targeting in Patient-derived Organoids and Cell Lines. (November 2020) Authors: Classen, S.; Rahlf, E.; Görte, J.; Parplys, A.C.; Schumacher, U.; Petersen, C.; Rothkamm, K.; Toulany, M.; Cordes, N.; Borgmann, K. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-1931 Identifying resistance mechanisms in breast cancer in patient-derived organoids and 3D cell culture. (August 2021) Authors: Classen, S.; Rahlf, E.; Petersen, C.; Rothkamm, K.; Toulany, M.; Cordes, N.; Borgmann, K. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗